EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exploring the glycation association with dyslipidaemia: Novel approach for diabetic nephropathy

Ashwini D Jagdale, Mukul M Angal, Rahul S Patil, Rashmi S Tupe

Biochemical Pharmacology · 2024

DOI: 10.1016/j.bcp.2024.116513 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2024. Verfasst von Ashwini D Jagdale und 3 weiteren Autor:innen. Beteiligte Einrichtung: Symbiosis School of Biological Sciences (SSBS), Symbiosis International (Deemed University) (SIU), Lavale, Pune, Maharashtra, India. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Glycation End Products, Advanced, Dyslipidemias, Sterol Regulatory Element Binding Proteins. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 181 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The transcription factor known as sterol regulatory element-binding protein (SREBP) and the glycation pathways, specifically the formation of Advanced Glycation End Products (AGEs), have a significant and deleterious impact on the kidney. They alter renal lipid metabolism and promote glomerulosclerosis, mesangial cell expansion, tubulointerstitial fibrosis, and inflammation, leading to diabetic nephropathy (DN) progression. Although several pieces of scientific evidence are reported for potential causes of glycation and lipotoxicity in DN, the underlying mechanism of renal lipid accumulation still needs to be fully understood. We provide a rationalized view on how AGEs exert multiple effects that cause SREBP activation and inflammation, contributing to DN through Receptor for AGEs (RAGE) signaling, AGE-R1-dependent downregulation of Sirtuin 1 (SIRT-1), and increased SREBP Cleavage Activating Protein (SCAP) glycosylation. This review emphasizes the association between glycation and the SREBP pathway and how it affects the onset of DN associated with obesity. Finally, we discuss the correlation of glycation and the SREBP pathway with insulin resistance (IR), oxidative stress, endoplasmic reticulum stress, inflammation, and existing and emerging therapeutic approaches toward better controlling obesity-related DN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesGlycation End Products, AdvancedDyslipidemiasSterol Regulatory Element Binding ProteinsHumansAnimalsGlycosylationReceptor for Advanced Glycation End Products

Stichwörter der Autor:innen

Diabetic nephropathyDyslipidemiaGlycationObesitySREBP pathway

Substanzen

Glycation End Products, AdvancedSterol Regulatory Element Binding ProteinsReceptor for Advanced Glycation End Products

Autor:innen und Institutionen

  • Symbiosis School of Biological Sciences (SSBS), Symbiosis International (Deemed University) (SIU), Lavale, Pune, Maharashtra, India.
  • Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, USA.
  • Symbiosis School of Biological Sciences (SSBS), Symbiosis International (Deemed University) (SIU), Lavale, Pune, Maharashtra, India. Electronic address: rashmi.tupe@ssbs.edu.in.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Jagdale, A. D., Angal, M. M., Patil, R. S., & Tupe, R. S. (2024). Exploring the glycation association with dyslipidaemia: Novel approach for diabetic nephropathy. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2024.116513

Vancouver

Jagdale AD, Angal MM, Patil RS, Tupe RS. Exploring the glycation association with dyslipidaemia: Novel approach for diabetic nephropathy. Biochemical Pharmacology. 2024. doi:10.1016/j.bcp.2024.116513

BibTeX
@article{Jagdale2024,
  author = {Jagdale, Ashwini D and Angal, Mukul M and Patil, Rahul S and Tupe, Rashmi S},
  title = {Exploring the glycation association with dyslipidaemia: Novel approach for diabetic nephropathy},
  journal = {Biochemical Pharmacology},
  year = {2024},
  doi = {10.1016/j.bcp.2024.116513}
}
Kostenlos starten →